We are live on ! Find out more
SOCM

SR One Capital Management Portfolio holdings

AUM $915M
1-Year Est. Return 209.71%
This Fund
S&P 500
This Quarter Est. Return
+9.64%
1 Year Est. Return
+209.71%
3 Year Est. Return
+484.66%
5 Year Est. Return
10 Year Est. Return
AUM
$219M
AUM Growth
+$14.4M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
4
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACLX
1
DELISTED
Arcellx
ACLX
$103M 47.19%
5,500,007
DSGN icon
2
Design Therapeutics
DSGN
$915M
$94.1M 43.01%
5,626,476
NKTX icon
3
Nkarta
NKTX
$167M
$17.5M 8.02%
1,333,333
EFTR
4
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
$3.89M 1.78%
272,885

Similar funds

SR One Capital Management's Q3 2022 Portfolio in Review

As of Q3 2022, SR One Capital Management held 4 positions worth $219M, up 7.1% from $204M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2022: portfolio turnover was 0%. SR One Capital Management opened no new positions and made no exits, leaving the 4-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • SR One Capital Management's ten largest holdings make up 100% of its $219M portfolio in Q3 2022.
  • SR One Capital Management opened 0 new positions and closed 0 in Q3 2022.
  • SR One Capital Management's portfolio value rose 7.1% quarter-over-quarter to $219M.

Based on SR One Capital Management's 13F filing for Q3 2022, filed 8 Nov 2022.